ERC Advanced Grants allow exceptional established research leaders to pursue ground-breaking, high-risk projects that open new directions in their respective research fields or other domains. They have been awarded for the fourth time this year. 2284 applications were submitted following the last call.
The grant will fund a project entitled "Transcriptional networks controlling lymphocyte development", or “LymphoControl” in short. The aim of the project is to elucidate how transcription factors regulate the development of B- and T-lymphocytes. These white blood cells are the main players in the body’s adaptive immune system.
They are derived from stem cells in the bone marrow and undergo several stages of differentiation before becoming fully functional, mature lymphocytes of the B- or T-cell lineage. Transcription factors are regulatory proteins encoded in the genome that control key stages in this process. Deregulation of the transcriptional control can severely disrupt the programmed cell fate and cause certain types of blood cancer.
Meinrad Busslinger has a long record in immunological research. He was the first to identify a critical factor, named Pax-5, which activates a B cell specific program in the precursor cells and suppresses alternative pathways. Pax-5 is also involved in the development of acute lymphoblastic leukemia in humans.
The project “LymphoControl” will build on previous research efforts, such as the creation of transgenic mice that carry molecular “tags” at the ends of transcription factors.
Busslinger is excited about the European commitment to basic research: “The ERC grant will allow us to carry out a project which requires massive human and technical resources. We have already established the required know-how and infrastructure, owing to the Austrian Science Fund and our sponsor Boehringer Ingelheim. Now we can really take full advantage of the exceptional facilities at the IMP.” The grant will also open career-paths for young researchers. Six additional scientists will be employed under the ERC-funded project.
Meinrad Busslinger was born in Switzerland in 1952. He studied Biochemistry at the ETH Zurich and obtained a doctorate in molecular biology from the University of Zurich. Following postdoctoral studies at the MRC Institute Mill Hill, London, he became a group leader at the University of Zurich. In 1987, he followed Max Birnstiel to the newly founded Research Institute of Molecular Pathology (IMP) in Vienna.
Busslinger is a Senior Scientist and Director of Academic Affairs at the IMP, Professor at the University of Vienna and a full member of the Austrian Academy of Sciences and of the European Molecular Biology Organisation EMBO. He has published over 130 papers in peer-reviewed journals and serves on the editorial boards of several scientific journals. Busslinger was awarded the Wittgenstein prize of the Austrian government in 2001 and the Virchow Medal by the University of Würzburg in 2010.
The recent allocation raises the number of ERC Grants awarded to IMP faculty to six: Barry Dickson succeeded in securing an advanced grant in the first round of evaluations in 2008. Stefan Westermann, Alexander Stark, Andrew Straw and Manuel Zimmer received ERC Starting Grants.
The Research Institute for Molecular Pathology carries out basic biomedical research in Vienna, Austria. Its main sponsor is Boehringer Ingelheim. Some 200 researchers from over 30 countries study life at molecular and cellular levels, information processing and storage in neural circuits, mechanisms of development and disease and interdisciplinary topics. The aim is a thorough understanding of complex biological processes that could lead to the development of new therapeutic concepts.Contact:
Dr. Heidemarie Hurtl | idw
Further reports about: > Advanced Investigator Grant > Boehringer > ERC Advanced Grants > ERC Starting Grant > European Molecular Biology > IMP > LymphoControl > Molecular Target > Pathology > Senior Citizens > biological process > blood cell > immune cells > lymphocyte development > transcription factor > white blood cell
Innovation Award of the United Nations Environment Programme for PhD Student from ZMT
22.03.2018 | Leibniz-Zentrum für Marine Tropenforschung (ZMT)
ERC Project set to boost application of adhesive structures
19.03.2018 | INM - Leibniz-Institut für Neue Materialien gGmbH
So-called quantum many-body scars allow quantum systems to stay out of equilibrium much longer, explaining experiment | Study published in Nature Physics
Recently, researchers from Harvard and MIT succeeded in trapping a record 53 atoms and individually controlling their quantum state, realizing what is called a...
The historic first detection of gravitational waves from colliding black holes far outside our galaxy opened a new window to understanding the universe. A...
A team led by Austrian experimental physicist Rainer Blatt has succeeded in characterizing the quantum entanglement of two spatially separated atoms by observing their light emission. This fundamental demonstration could lead to the development of highly sensitive optical gradiometers for the precise measurement of the gravitational field or the earth's magnetic field.
The age of quantum technology has long been heralded. Decades of research into the quantum world have led to the development of methods that make it possible...
Cardiovascular tissue engineering aims to treat heart disease with prostheses that grow and regenerate. Now, researchers from the University of Zurich, the Technical University Eindhoven and the Charité Berlin have successfully implanted regenerative heart valves, designed with the aid of computer simulations, into sheep for the first time.
Producing living tissue or organs based on human cells is one of the main research fields in regenerative medicine. Tissue engineering, which involves growing...
A team of scientists of the Max Planck Institute for the Structure and Dynamics of Matter (MPSD) at the Center for Free-Electron Laser Science in Hamburg investigated optically-induced superconductivity in the alkali-doped fulleride K3C60under high external pressures. This study allowed, on one hand, to uniquely assess the nature of the transient state as a superconducting phase. In addition, it unveiled the possibility to induce superconductivity in K3C60 at temperatures far above the -170 degrees Celsius hypothesized previously, and rather all the way to room temperature. The paper by Cantaluppi et al has been published in Nature Physics.
Unlike ordinary metals, superconductors have the unique capability of transporting electrical currents without any loss. Nowadays, their technological...
02.05.2018 | Event News
13.04.2018 | Event News
12.04.2018 | Event News
18.05.2018 | Power and Electrical Engineering
18.05.2018 | Information Technology
18.05.2018 | Information Technology